AR022578A1 - Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial - Google Patents

Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial

Info

Publication number
AR022578A1
AR022578A1 ARP000100605A ARP000100605A AR022578A1 AR 022578 A1 AR022578 A1 AR 022578A1 AR P000100605 A ARP000100605 A AR P000100605A AR P000100605 A ARP000100605 A AR P000100605A AR 022578 A1 AR022578 A1 AR 022578A1
Authority
AR
Argentina
Prior art keywords
artificial
preparation
surface activity
tensioactive
same
Prior art date
Application number
ARP000100605A
Other languages
English (en)
Spanish (es)
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of AR022578A1 publication Critical patent/AR022578A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP000100605A 1999-02-12 2000-02-11 Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial AR022578A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI000275A IT1308180B1 (it) 1999-02-12 1999-02-12 Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Publications (1)

Publication Number Publication Date
AR022578A1 true AR022578A1 (es) 2002-09-04

Family

ID=11381859

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100605A AR022578A1 (es) 1999-02-12 2000-02-11 Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial

Country Status (33)

Country Link
US (1) US7053044B1 (sk)
EP (1) EP1151008B1 (sk)
JP (1) JP4754073B2 (sk)
KR (1) KR100645145B1 (sk)
CN (1) CN1221570C (sk)
AR (1) AR022578A1 (sk)
AT (1) ATE280181T1 (sk)
AU (1) AU758735B2 (sk)
BG (1) BG65196B1 (sk)
BR (1) BR0009964A (sk)
CA (1) CA2362507C (sk)
CO (1) CO5241361A1 (sk)
CZ (1) CZ301108B6 (sk)
DE (1) DE60015082T2 (sk)
EA (1) EA004058B1 (sk)
EE (1) EE04879B1 (sk)
ES (1) ES2228473T3 (sk)
GE (1) GEP20032976B (sk)
HK (1) HK1042500A1 (sk)
HU (1) HU228997B1 (sk)
IL (1) IL144842A0 (sk)
IT (1) IT1308180B1 (sk)
MA (1) MA25381A1 (sk)
NO (1) NO20013888D0 (sk)
NZ (1) NZ513451A (sk)
PL (1) PL201084B1 (sk)
PT (1) PT1151008E (sk)
SK (1) SK286428B6 (sk)
TR (1) TR200102308T2 (sk)
UA (1) UA72751C2 (sk)
WO (1) WO2000047623A1 (sk)
YU (1) YU57701A (sk)
ZA (1) ZA200106530B (sk)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
CA2399944A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
PT1340506E (pt) * 2002-03-01 2007-03-30 Chiesi Farma Spa Composições que incluem surfactantes pulmonares e uma polimixina que melhoram as propriedades da superfície
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
CN100401896C (zh) * 2002-12-09 2008-07-16 儿童医院医疗中心 诊断和治疗间质性肺病的方法
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
EP1660098A1 (en) * 2003-08-28 2006-05-31 ALTANA Pharma AG Use of surfactant preparations for the treatment of surgical adhesions
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
EP2049554A4 (en) 2006-07-20 2011-06-29 Univ Rochester Medical Ct SYNTHETIC PULMONARY SURFACTANT AND USE THEREOF
ZA200902481B (en) * 2006-10-13 2010-07-28 Chiesi Farma Spa Reconstituted surfactants having improved properties
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
US8048043B2 (en) 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
NZ593892A (en) 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
EP2475373B1 (en) 2009-09-08 2013-11-13 Chiesi Farmaceutici S.p.A. A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
IN2014DN09602A (sk) * 2012-04-23 2015-07-31 Chiesi Farma Spa
BR112015009486B1 (pt) * 2012-11-21 2022-06-14 Chiesi Farmaceutici S.P.A Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído
EP3106090A1 (en) 2015-06-15 2016-12-21 CHIESI FARMACEUTICI S.p.A. System for effective breath-synchronized delivery of medicament to the lungs
ES2827948T3 (es) 2015-04-22 2021-05-25 Chiesi Farm Spa Sistema eficaz para la administración de medicamento sincronizada con la respiración a los pulmones
WO2016173634A1 (en) 2015-04-28 2016-11-03 Chiesi Farmaceutici S.P.A Device for facilitating the administration of a medicament to the lung by a catheter
EP3288579A1 (en) 2015-04-30 2018-03-07 University of Bremen A novel skin medical and cosmetic care product
MX2019000651A (es) 2016-07-28 2019-04-01 Chiesi Farm Spa Metodo y sistema para suministro de medicamento en aerosol.
CN109890446B (zh) 2016-10-26 2022-03-22 奇斯药制品公司 用于帮助通过导管向肺给送药剂的装置
PL3558376T3 (pl) 2016-12-22 2022-02-14 Chiesi Farmaceutici S.P.A. Kombinacja terapeutyczna zawierająca surfaktant płucny i steroid do leczenia rozwijającej się BPD
TW201927286A (zh) 2017-12-15 2019-07-16 義大利商凱西製藥公司 用於噴霧投藥之包含肺表面張力素的藥學調配物
WO2019115771A1 (en) 2017-12-15 2019-06-20 Pari Pharma Gmbh Nebuliser system, holding system, combination comprising nebuliser system and holding system, and aerosol administration method
WO2019206731A1 (en) 2018-04-23 2019-10-31 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the prophylaxis of bpd
EP3666316A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3666315A1 (en) 2018-12-14 2020-06-17 PARI Pharma GmbH Aerosol delivery device and method of operating the aerosol delivery device
EP3843105A1 (en) 2019-12-23 2021-06-30 PARI Pharma GmbH Control device for aerosol nebulizer system
WO2021151853A1 (en) 2020-01-28 2021-08-05 Chiesi Farmaceutici S.P.A. Polypeptides having improved properties
CN114159546B (zh) * 2021-12-20 2024-06-04 北京双鹤润创科技有限公司 新一代合成肺表面活性物质制剂及其临床应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104853A (en) * 1984-12-11 1992-04-14 California Biotechnology Inc. Alveolar surfactant proteins having cys to ser mutations
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
NZ277095A (en) * 1993-12-08 1997-09-22 Tokyo Tanabe Co Peptide that exhibits potent surface activity, lung surfactant containing such and its use in treating respiratory distress syndrome
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante

Also Published As

Publication number Publication date
PL349785A1 (en) 2002-09-09
PT1151008E (pt) 2005-01-31
US7053044B1 (en) 2006-05-30
KR20010101904A (ko) 2001-11-15
KR100645145B1 (ko) 2006-11-10
NO20013888L (no) 2001-08-09
AU3279300A (en) 2000-08-29
CO5241361A1 (es) 2003-01-31
EP1151008B1 (en) 2004-10-20
EP1151008A1 (en) 2001-11-07
ITMI990275A1 (it) 2000-08-12
PL201084B1 (pl) 2009-03-31
CZ301108B6 (cs) 2009-11-11
HK1042500A1 (en) 2002-08-16
JP4754073B2 (ja) 2011-08-24
HUP0200141A2 (en) 2002-06-29
ATE280181T1 (de) 2004-11-15
ES2228473T3 (es) 2005-04-16
CA2362507C (en) 2012-01-03
BG65196B1 (bg) 2007-06-29
EE04879B1 (et) 2007-08-15
DE60015082D1 (de) 2004-11-25
TR200102308T2 (tr) 2002-04-22
CN1340060A (zh) 2002-03-13
WO2000047623A1 (en) 2000-08-17
UA72751C2 (en) 2005-04-15
AU758735B2 (en) 2003-03-27
HU228997B1 (en) 2013-07-29
EA004058B1 (ru) 2003-12-25
HUP0200141A3 (en) 2002-09-30
NO20013888D0 (no) 2001-08-09
BR0009964A (pt) 2002-04-09
IT1308180B1 (it) 2001-12-07
IL144842A0 (en) 2002-06-30
CN1221570C (zh) 2005-10-05
EA200100749A1 (ru) 2002-02-28
EE200100413A (et) 2002-12-16
YU57701A (sh) 2003-07-07
MA25381A1 (fr) 2002-04-01
SK11442001A3 (sk) 2001-12-03
CA2362507A1 (en) 2000-08-17
DE60015082T2 (de) 2006-02-09
JP2002541062A (ja) 2002-12-03
BG105764A (en) 2002-03-29
CZ20012876A3 (cs) 2002-06-12
GEP20032976B (en) 2003-05-27
ZA200106530B (en) 2002-10-14
SK286428B6 (sk) 2008-09-05
NZ513451A (en) 2003-05-30

Similar Documents

Publication Publication Date Title
AR022578A1 (es) Peptidos artificiales que tienen actividad superficial y el uso de los mismos en la preparacion de un tensioactivo artificial
ES2071306T3 (es) El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
AR015493A1 (es) DERIVADOS CICLOHEXILOS , COMPOSICIONES FARMACÉUTICAS Y EL USO DE LOS MISMOS PARA LA MANUFACTURA DE UNA COMPOSICIoN uTIL PARA INHIBIR LA ACTIVIDAD IN VITRO DE NEURAMINIDASA Y PARA EL TRATAMIENTO O PROFILAXIS DE LA INFECCIoN DE INFLUENZA Y PARA TRATAIMIENTO, Y UN MÉTODO IN VITRO PARA INHIBIR LA ACTIVI
PE20000721A1 (es) Articulo absorbente que incluye un agente modificador de heces basado en calcio
PE20080339A1 (es) Polipeptidos del factor de coagulacion ix modificados y uso de los mismos para tratamiento
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
UY27720A1 (es) Aroilpiridinonas monocíclicas,
ES2194720T3 (es) Enzimas para el tratamiento de diabetes mellitus tipo i.
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
IS2822B (is) Hindrar á mennskt fosfatidýl-inósítól 3-kínasa delta
CY1106667T1 (el) Βελτιωμενα συνθετικα μιγματα λιπιδιων για την παρασκευη μιας ανασυγκροτημενης επιφανειοδραστικης ουσιας
ATE333896T1 (de) Vaskularisierungsinhibitoren
ES2172680T3 (es) Ligante antagonista rar-gamma o agonista rar-alfa como inhibidor de apoptosis.
AR042039A1 (es) Isomeros posicionales del ifn peg alfa 2 a
GT199900010A (es) Nuevas sulfonamidas naftil- y anilido-substituidas.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ATE120207T1 (de) Zusammensetzung zur aktivierung der makrophagen.
ATE399558T1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
AR038642A1 (es) Tensioactivos pulmonares que contienen una polimixina para mejorar las propiedades superficiales
AR028589A1 (es) PROCEDIMIENTO PARA PREPARAR COMPUESTOS DE BIFENILO Y PROCEDIMIENTO PARA REDUCIR EL NIVEL DE DíMERO AQUIRAL EN LOS COMPUESTOS DE BIFENILO PREPARADOS
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.